Harrow, Inc. (HROW)
39.29
+0.24
(+0.61%)
USD |
NASDAQ |
May 08, 09:34
Harrow Research and Development Expense (Annual) : 12.85M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Esperion Therapeutics, Inc. | 47.85M |
| Hims & Hers Health, Inc. | 149.30M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Theravance Biopharma, Inc. | 35.91M |